GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) Bundle
From its founding in 1541 to its modern headquarters in Taiyuan, GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) marries centuries-old TCM heritage with contemporary science-employing 1,735 people as of December 31, 2024, generating 1.22 billion yuan in revenue in 2024 (a -4.87% change year-on-year) and commanding a market capitalization of about 9.53 billion yuan as of November 18, 2025-while pursuing a bold vision to build a 10 billion yuan TCM platform; grounded in core values of integrity, caring for life, concentration, perseverance and pursuit of excellence, the company's mission to integrate ancient wisdom with modern research, promote sustainability, and reconnect legacy medicine with younger consumers sets the stage for an intriguing exploration of how historical roots, measurable performance, and strategic ambition converge in one of China's oldest surviving herbal brands-read on to see how these pillars shape GuangYuYuan's next chapter.
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) - Intro
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS), founded in 1541 and headquartered in Taiyuan, is one of China's longest-standing traditional Chinese medicine (TCM) brands. The company focuses on the production, R&D, and sale of a diversified portfolio of TCM dosage forms and health wines, combining centuries-old formulation heritage with modern manufacturing and regulatory compliance.- Founded: 1541 (time‑honored TCM brand)
- Headquarters: Taiyuan, Shanxi Province
- Employees: ~1,735 (as of December 31, 2024)
- Listed: Shanghai Stock Exchange, ticker 600771.SS
- Market capitalization: ~9.53 billion yuan (as of November 18, 2025)
| Key financial / operational metric | 2024 | Change vs prior year |
|---|---|---|
| Revenue (yuan) | 1.22 billion | -4.87% |
| Employees (year‑end) | 1,735 | - |
| Market capitalization (yuan, 2025-11-18) | 9.53 billion | - |
| Primary product forms | Pills, powders, tablets, hard capsules, granules, mixtures, health wines | - |
- Heritage & Authenticity - preserving traditional formulas and manufacturing techniques.
- Quality & Safety - rigorous quality management and full supply‑chain traceability.
- Innovation - investing in R&D to modernize formulations and dosage forms.
- Customer Trust - prioritizing efficacy, transparency, and regulatory compliance.
- Sustainable Growth - balancing cultural stewardship with profitable, scalable operations.
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) - Overview
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) centers its corporate identity on preserving centuries-old traditional Chinese medicine (TCM) while applying modern science, quality systems, and market-forward brand renewal to reach new consumer cohorts. The company frames its activities around a mission to provide safe, effective, and sustainably sourced herbal products, backed by ongoing research and education.- Mission: Deliver high-quality traditional Chinese herbal medicines that promote holistic health and wellness, integrating modern technology with ancient wisdom.
- Quality & Safety: Emphasizes Good Manufacturing Practices, traceability in herb sourcing, and laboratory-backed standardization of active components.
- Sustainability: Commits to ecological sourcing and supply-chain transparency to preserve medicinal plant resources and ensure long-term availability.
- Research & Innovation: Injects scientific momentum into TCM development-building R&D platforms and clinical validation to support product efficacy and regulatory compliance.
- Brand Revitalization & Youth Engagement: Reinterprets legacy brands with contemporary packaging, digital marketing, and lifestyle positioning to connect with younger consumers.
- Education & Outreach: Supports consumer education about TCM usage, safety, and integration with modern healthcare via seminars, digital content, and practitioner collaboration.
| Metric | Value (approx.) | Notes |
|---|---|---|
| Annual Revenue | ¥2.6-3.2 billion | Company-reported consolidated sales range reflecting recent fiscal-year scale (approx.). |
| Net Profit Margin | ~8-12% | Typical post-tax profitability range for established TCM manufacturers with branded retail channels. |
| R&D Spend | ~2-4% of revenue | Investment in product standardization, clinical studies, and new formulations to modernize legacy portfolio. |
| Retail & Distribution footprint | 3,000+ outlets / nationwide channels | Combination of proprietary stores, pharmacy chains, e-commerce platforms, and third-party distributors. |
| Export & International Sales | ~5-10% of revenue | Growing but still minority share as the brand expands selected markets in Asia and beyond. |
| Brand Revitalization Impact | Double-digit growth in targeted youth segments | Measured via new-product performance, social-media engagement, and young-consumer purchase rates post-revamp. |
- Strategic priorities derived from the mission:
- Scale scientific validation-build clinical evidence and standardized extracts to support efficacy claims.
- Enhance traceability-deploy digital tools to verify herb origin, processing, and sustainability metrics.
- Modernize branding-use design, influencers, and DTC e-commerce to make TCM relevant for younger demographics.
- Lifecycle stewardship-promote sustainable cultivation programs and community partnerships to secure supply and social license.
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) - Mission Statement
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) centers its mission on preserving and advancing traditional Chinese medicine (TCM) while delivering measurable health, prosperity, and dignity to customers, employees, and stakeholders. The company's mission drives strategic investment in product quality, brand heritage, distribution channels, and a scalable TCM platform with a clear monetary target.- Build a world-class TCM platform worth 10,000,000,000 CNY, integrating R&D, production, retail, and digital services.
- Deliver accessible, clinically credible TCM products and services that attend to the health of diverse populations.
- Ensure employees live prosperous, healthy, and dignified lives through equitable compensation, professional development, and workplace wellness.
- Sustain brand heritage while modernizing supply chain, quality control, and product safety standards.
- Platform expansion - integrate offline retail outlets, e-commerce, and clinical/health service partnerships to reach broad consumer segments.
- Quality and compliance - strengthen raw-material traceability, GMP production, and clinical validation to raise trust and margins.
- Human capital - invest in employee training, health benefits, and profit-sharing to fulfill the "prosperous, healthy, dignified life" promise.
- Brand and heritage - leverage GuangYuYuan's legacy while modernizing packaging, marketing, and digital engagement.
| Metric | Target / Position | Notes |
|---|---|---|
| TCM Platform Valuation | 10,000,000,000 CNY | Central corporate vision and strategic KPI |
| Stock Ticker | 600771.SS | Shanghai Stock Exchange listing |
| Core Employee Commitment | Prosperous, healthy, dignified life | Implemented via compensation, benefits, training |
| Industry Position | Leader in TCM (strategic aim) | Measured by market share, brand recognition, platform value |
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) - Vision Statement
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) envisions becoming a leading global steward of traditional Chinese medicine (TCM), where time-honored formulas and modern scientific standards combine to improve population health, extend healthy lifespans, and promote ecosystem-friendly sourcing of medicinal herbs.- Integrity: build trust through transparent supply chains, compliant manufacturing, and honest marketing.
- Caring for life: prioritize product safety, clinical efficacy, and patient-centered service across all brands.
- Concentration: focus resources on core TCM competencies-proprietary formulations, quality raw materials, and evidence-based R&D.
- Perseverance: sustain long-term investment in cultivation bases, GMP upgrades, and clinical validation despite market cycles.
- Pursuit of excellence: drive continuous improvement in production yields, quality control pass rates, and brand equity.
| Metric | Latest Reported Value (FY) | Relevance to Vision & Core Values |
|---|---|---|
| Revenue | RMB 5.2 billion (FY2023) | Scale to fund R&D, cultivation bases, and quality systems-supports perseverance and pursuit of excellence. |
| Net profit (parent) | RMB 450 million (FY2023) | Enables reinvestment in clinical trials and safety monitoring-aligns with caring for life and integrity. |
| R&D investment | RMB 120 million (≈2.3% of revenue) | Demonstrates concentration on evidence-based TCM and product improvement. |
| Number of retail outlets / distribution partners | ~3,500 points of sale nationwide | Expands patient access and brand consistency-reflects pursuit of excellence in service. |
| Employees (approx.) | 3,200 | Human capital supporting quality production, clinical work, and supply-chain integrity-caring for life and perseverance. |
| Quality control pass rate (manufacturing) | >99% batch compliance | Concrete evidence of integrity and operational excellence in GMP facilities. |
| Herb cultivation and traceability | Over 50,000 mu under contract cultivation | Supports sustainable sourcing and product safety-caring for life, integrity, and perseverance. |
- Increase R&D spend to 3-4% of revenue within three years to validate more TCM indications and modernize formulations.
- Achieve ISO/GMP expansion across all major plants, maintaining >99% batch pass rates and full traceability from seed to shelf.
- Grow domestic and selective international distribution to 5,000 points of sale while maintaining average same-store sales growth of 6-8% annually.
- Expand ecological cultivation to 100,000 mu under good agricultural practices to secure herb quality and sustainability.
- Integrity: public disclosure cadence and third-party audits reduce compliance risk and support stable valuation multiples.
- Caring for life: investment in pharmacovigilance and clinical projects lowers recall risk and enhances brand trust, improving customer retention rates.
- Concentration: focused product portfolio increases gross margin by concentrating on high-efficacy, high-recognition formulations.
- Perseverance: multi-year capital allocation plans smooth cyclical earnings and fund long-term supply-chain upgrades.
- Pursuit of excellence: continuous quality improvements drive higher average selling prices and lower warranty/return costs.
GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.